Is Office-based Management of Intermediate-risk Low-grade Non–muscle-invasive Bladder Cancer Ready For Prime Time?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is Office-based Management of Intermediate-risk Low-grade Non–muscle-invasive Bladder Cancer Ready For Prime Time?

Published:2023-02 Issue:2 Volume:83 Page:131-132
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Taylor Jacob,Lotan Yair

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. GLOBOCAN. Cancer incidence and mortality worldwide 2020 v1.0. https://gco.iarc.fr/.

2. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016

3. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

4. Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm;Donat;J Urol,2004

5. An analysis of the efficacy, safety, and cost-effectiveness of fulguration under local anesthesia for small-sized recurrent masses: a comparative analysis to transurethral resection of bladder tumors in a matched cohort;Park;J Endourol,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3